We hypothesised that ( 1 ) insulin would fail to increase mitochondrial oxidative capacity in non-diabetic insulin-resistant young obese humans and in elderly patients with type 2 diabetes and ( 2 ) reducing NEFA levels would improve insulin sensitivity by raising oxidative capacity and lowering oxidative stress .